ROR2
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| O43707 | Y906 | Sugiyama | ACTN4 | yQGPDAVPGALDyKsFStALyGEsDL_______________ |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P11142 | T427 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | GGVMTVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGER |
| P11142 | Y443 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KQtQtFttysDNQPGVLIQVyEGERAMTKDNNLLGKFELTG |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P29320 | Y596 | Sugiyama | EPHA3 ETK ETK1 HEK TYRO4 | ADEKRLHFGNGHLKLPGLRtyVDPHtyEDPtQAVHEFAKEL |
| P29320 | Y937 | Sugiyama | EPHA3 ETK ETK1 HEK TYRO4 | GDWLNGVWTAHCKEIFtGVEyssCDTIAKISTDDMKKVGVT |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y265 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | PHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMM |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q01974 | S447 | Sugiyama | ROR2 NTRKR2 | MCRNKQKASASTPQRRQLMAsPsQDMEMPLINQHKQAKLKE |
| Q01974 | S469 | Sugiyama | ROR2 NTRKR2 | sQDMEMPLINQHKQAKLKEIsLSAVRFMEELGEDRFGKVYK |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q92882 | Y207 | Sugiyama | OSTF1 | sLLKKKQGTDAVRtLsNAEDyLDDEDsD_____________ |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Regulation of CDH1 Function | R-HSA-9764561 | 1.003766e-09 | 8.998 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.398122e-09 | 8.194 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.523805e-08 | 7.344 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.690282e-07 | 6.772 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.343166e-07 | 6.630 | 1 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.639599e-07 | 6.578 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.032017e-06 | 5.986 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.313435e-06 | 5.882 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.686509e-06 | 5.433 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.594004e-06 | 5.338 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.480548e-06 | 5.188 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.880662e-06 | 5.103 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.550558e-06 | 5.068 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.672757e-05 | 4.777 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.672757e-05 | 4.777 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.004005e-05 | 4.698 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.764574e-05 | 4.558 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.055885e-05 | 4.515 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.666688e-05 | 4.436 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.853549e-05 | 4.414 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.606057e-05 | 4.443 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 3.903773e-05 | 4.409 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.394266e-05 | 4.469 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.278883e-05 | 4.277 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.254399e-05 | 4.279 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.771988e-05 | 4.169 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.724426e-05 | 4.112 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.024397e-04 | 3.990 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.150454e-04 | 3.939 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.249355e-04 | 3.903 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.245030e-04 | 3.905 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.413432e-04 | 3.850 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.375281e-04 | 3.862 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.502818e-04 | 3.823 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.651295e-04 | 3.782 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.791360e-04 | 3.747 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.783203e-04 | 3.749 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.309515e-04 | 3.636 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.429244e-04 | 3.615 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.542119e-04 | 3.595 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.689532e-04 | 3.570 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.562018e-04 | 3.448 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.507775e-04 | 3.455 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.483879e-04 | 3.458 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.483879e-04 | 3.458 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.483879e-04 | 3.458 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.109787e-04 | 3.507 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.730569e-04 | 3.428 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.975515e-04 | 3.401 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.018038e-04 | 3.396 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.555818e-04 | 3.341 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.466322e-04 | 3.350 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.732409e-04 | 3.325 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.833584e-04 | 3.316 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.199579e-04 | 3.284 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.652667e-04 | 3.248 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.815300e-04 | 3.107 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.278277e-04 | 3.082 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.423846e-04 | 3.026 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.846574e-04 | 3.007 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.082507e-03 | 2.966 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.035990e-03 | 2.985 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.106226e-03 | 2.956 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.136323e-03 | 2.944 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.136323e-03 | 2.944 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.136323e-03 | 2.944 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.245732e-03 | 2.905 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.262427e-03 | 2.899 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.275141e-03 | 2.894 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.300519e-03 | 2.886 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.471062e-03 | 2.832 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.439770e-03 | 2.842 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.480633e-03 | 2.830 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.558385e-03 | 2.807 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.610835e-03 | 2.793 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.610835e-03 | 2.793 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.749257e-03 | 2.757 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.749257e-03 | 2.757 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.736206e-03 | 2.760 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.896205e-03 | 2.722 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.946063e-03 | 2.711 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.051986e-03 | 2.688 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.093591e-03 | 2.679 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.249096e-03 | 2.648 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.249096e-03 | 2.648 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.309799e-03 | 2.636 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.561923e-03 | 2.591 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.575413e-03 | 2.589 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.503921e-03 | 2.601 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.391279e-03 | 2.621 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.363208e-03 | 2.626 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.503921e-03 | 2.601 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.694046e-03 | 2.570 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.694046e-03 | 2.570 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.769619e-03 | 2.558 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.769619e-03 | 2.558 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.769619e-03 | 2.558 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 3.008974e-03 | 2.522 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.160867e-03 | 2.500 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.189494e-03 | 2.496 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.974208e-03 | 2.527 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.444478e-03 | 2.463 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.121620e-03 | 2.506 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 3.415786e-03 | 2.467 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.430453e-03 | 2.465 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.832318e-03 | 2.548 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.086831e-03 | 2.510 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.462027e-03 | 2.461 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.031618e-03 | 2.518 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.162857e-03 | 2.500 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 3.160867e-03 | 2.500 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.332426e-03 | 2.477 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.144493e-03 | 2.502 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.347519e-03 | 2.475 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.674379e-03 | 2.435 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.674379e-03 | 2.435 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.674379e-03 | 2.435 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.674379e-03 | 2.435 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.824960e-03 | 2.417 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.956062e-03 | 2.403 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.100394e-03 | 2.387 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.109167e-03 | 2.386 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.770690e-03 | 2.321 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.846878e-03 | 2.315 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.873258e-03 | 2.312 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.873258e-03 | 2.312 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.315541e-03 | 2.365 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.480248e-03 | 2.349 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.873258e-03 | 2.312 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.770690e-03 | 2.321 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.483994e-03 | 2.261 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.193126e-03 | 2.285 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.288770e-03 | 2.277 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.283654e-03 | 2.277 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.283654e-03 | 2.277 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.508316e-03 | 2.259 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.273130e-03 | 2.278 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.727343e-03 | 2.242 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.288770e-03 | 2.277 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.727343e-03 | 2.242 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.727343e-03 | 2.242 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.659521e-03 | 2.247 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.501556e-03 | 2.260 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.518319e-03 | 2.258 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.283654e-03 | 2.277 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.928109e-03 | 2.307 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.644000e-03 | 2.248 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.011061e-03 | 2.300 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.592760e-03 | 2.252 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.367770e-03 | 2.270 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.998753e-03 | 2.222 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.998753e-03 | 2.222 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.998753e-03 | 2.222 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.062161e-03 | 2.217 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.221354e-03 | 2.206 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.221354e-03 | 2.206 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.348261e-03 | 2.197 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.660625e-03 | 2.176 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.675839e-03 | 2.175 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.675839e-03 | 2.175 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.719702e-03 | 2.173 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 7.464806e-03 | 2.127 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.591457e-03 | 2.120 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.911713e-03 | 2.102 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.284748e-03 | 2.082 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.806115e-03 | 2.108 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.722954e-03 | 2.112 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.777662e-03 | 2.109 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.464806e-03 | 2.127 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.284748e-03 | 2.082 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.284748e-03 | 2.082 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.986986e-03 | 2.156 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.406413e-03 | 2.130 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.284748e-03 | 2.082 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.284748e-03 | 2.082 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.274878e-03 | 2.082 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.186815e-03 | 2.143 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.783447e-03 | 2.056 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.783447e-03 | 2.056 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.243270e-03 | 2.034 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.243270e-03 | 2.034 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.243270e-03 | 2.034 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.282941e-03 | 2.032 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.608068e-03 | 2.017 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.719427e-03 | 2.012 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.012875e-02 | 1.994 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.012875e-02 | 1.994 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.051653e-02 | 1.978 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.079778e-02 | 1.967 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.079778e-02 | 1.967 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.079778e-02 | 1.967 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.142286e-02 | 1.942 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.367847e-02 | 1.864 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 1.163282e-02 | 1.934 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.284235e-02 | 1.891 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.333025e-02 | 1.875 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.149470e-02 | 1.940 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.149470e-02 | 1.940 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.149470e-02 | 1.940 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.149470e-02 | 1.940 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.367847e-02 | 1.864 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.149470e-02 | 1.940 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.101581e-02 | 1.958 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.221991e-02 | 1.913 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.297380e-02 | 1.887 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.168010e-02 | 1.933 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.220189e-02 | 1.914 | 1 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.284235e-02 | 1.891 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.358272e-02 | 1.867 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.142286e-02 | 1.942 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.367847e-02 | 1.864 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.293408e-02 | 1.888 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.342973e-02 | 1.872 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.368022e-02 | 1.864 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.383098e-02 | 1.859 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.388478e-02 | 1.857 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.388478e-02 | 1.857 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.414794e-02 | 1.849 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.416723e-02 | 1.849 | 1 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.416903e-02 | 1.849 | 0 | 0 |
| Translation | R-HSA-72766 | 1.427003e-02 | 1.846 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.431048e-02 | 1.844 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.482300e-02 | 1.829 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.541176e-02 | 1.812 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.541176e-02 | 1.812 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.569407e-02 | 1.804 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.583356e-02 | 1.800 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.583356e-02 | 1.800 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.583356e-02 | 1.800 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.583356e-02 | 1.800 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.583356e-02 | 1.800 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.583356e-02 | 1.800 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.583356e-02 | 1.800 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.583356e-02 | 1.800 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 1.610867e-02 | 1.793 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.611009e-02 | 1.793 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.611009e-02 | 1.793 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.611009e-02 | 1.793 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.628327e-02 | 1.788 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.636723e-02 | 1.786 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 1.636723e-02 | 1.786 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.636723e-02 | 1.786 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.651404e-02 | 1.782 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.653266e-02 | 1.782 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.682714e-02 | 1.774 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.718578e-02 | 1.765 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.718578e-02 | 1.765 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.769563e-02 | 1.752 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.871162e-02 | 1.728 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.147711e-02 | 1.668 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.811895e-02 | 1.742 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.055524e-02 | 1.687 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.305169e-02 | 1.637 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.222667e-02 | 1.653 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.055524e-02 | 1.687 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.110510e-02 | 1.676 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.216351e-02 | 1.654 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 1.874185e-02 | 1.727 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.871162e-02 | 1.728 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.147711e-02 | 1.668 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.908305e-02 | 1.719 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.007835e-02 | 1.697 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.089691e-02 | 1.680 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.041188e-02 | 1.690 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.925330e-02 | 1.715 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.007835e-02 | 1.697 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.374882e-02 | 1.624 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.405807e-02 | 1.619 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.437618e-02 | 1.613 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 2.437618e-02 | 1.613 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.482039e-02 | 1.605 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.508718e-02 | 1.601 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.521543e-02 | 1.598 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.521543e-02 | 1.598 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.536701e-02 | 1.596 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.553082e-02 | 1.593 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.573653e-02 | 1.589 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.679613e-02 | 1.572 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.747553e-02 | 1.561 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.757490e-02 | 1.559 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.763315e-02 | 1.559 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.812961e-02 | 1.551 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.839447e-02 | 1.547 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.861390e-02 | 1.543 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.863328e-02 | 1.543 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.863328e-02 | 1.543 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.874947e-02 | 1.541 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.042967e-02 | 1.517 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.047511e-02 | 1.516 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.070008e-02 | 1.513 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.070008e-02 | 1.513 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.070008e-02 | 1.513 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.141739e-02 | 1.503 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.141739e-02 | 1.503 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.141739e-02 | 1.503 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.141739e-02 | 1.503 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.141739e-02 | 1.503 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.228412e-02 | 1.491 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.228412e-02 | 1.491 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.273311e-02 | 1.485 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.344249e-02 | 1.476 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.364967e-02 | 1.473 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.384695e-02 | 1.470 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.406481e-02 | 1.468 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.419638e-02 | 1.466 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.419638e-02 | 1.466 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.496020e-02 | 1.456 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 4.675539e-02 | 1.330 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 4.675539e-02 | 1.330 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.756589e-02 | 1.425 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.883654e-02 | 1.311 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.883654e-02 | 1.311 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.283299e-02 | 1.277 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.027699e-02 | 1.395 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.027699e-02 | 1.395 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.725408e-02 | 1.429 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.888102e-02 | 1.410 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.251716e-02 | 1.280 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.027699e-02 | 1.395 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.020080e-02 | 1.299 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.461364e-02 | 1.351 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.686558e-02 | 1.329 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.119818e-02 | 1.385 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.119818e-02 | 1.385 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.686558e-02 | 1.329 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.241730e-02 | 1.372 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.005323e-02 | 1.301 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.756589e-02 | 1.425 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.819315e-02 | 1.418 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.181095e-02 | 1.286 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.756589e-02 | 1.425 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.119818e-02 | 1.385 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.468029e-02 | 1.350 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.181095e-02 | 1.286 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.143131e-02 | 1.383 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.039831e-02 | 1.394 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.353280e-02 | 1.361 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.843489e-02 | 1.415 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.686558e-02 | 1.329 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 4.709186e-02 | 1.327 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.039831e-02 | 1.394 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.283299e-02 | 1.277 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.725685e-02 | 1.429 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.803458e-02 | 1.420 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.739702e-02 | 1.427 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.762236e-02 | 1.425 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.552781e-02 | 1.342 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.888102e-02 | 1.410 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.888102e-02 | 1.410 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.756589e-02 | 1.425 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.917263e-02 | 1.308 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.461364e-02 | 1.351 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.848130e-02 | 1.415 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.338551e-02 | 1.363 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.338551e-02 | 1.363 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.020080e-02 | 1.299 | 1 | 1 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.373354e-02 | 1.270 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.373354e-02 | 1.270 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.395000e-02 | 1.268 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.395000e-02 | 1.268 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.427508e-02 | 1.265 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.553340e-02 | 1.255 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.641925e-02 | 1.249 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.641925e-02 | 1.249 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.641925e-02 | 1.249 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.694139e-02 | 1.245 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.771738e-02 | 1.239 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.810263e-02 | 1.236 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 5.894142e-02 | 1.230 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.894142e-02 | 1.230 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.941358e-02 | 1.226 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.074209e-02 | 1.217 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.115723e-02 | 1.214 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.115723e-02 | 1.214 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.115723e-02 | 1.214 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.119310e-02 | 1.213 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.151593e-02 | 1.211 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.185144e-02 | 1.209 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.185144e-02 | 1.209 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.185144e-02 | 1.209 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.185144e-02 | 1.209 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.313941e-02 | 1.200 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.547612e-02 | 1.184 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.547612e-02 | 1.184 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.547612e-02 | 1.184 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.712875e-02 | 1.173 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.917146e-02 | 1.160 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.954714e-02 | 1.158 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.989375e-02 | 1.156 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.989375e-02 | 1.156 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.192206e-02 | 1.143 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.232457e-02 | 1.141 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.232457e-02 | 1.141 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.335208e-02 | 1.135 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.348971e-02 | 1.134 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 7.670934e-02 | 1.115 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 7.670934e-02 | 1.115 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.765833e-02 | 1.110 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.094824e-02 | 1.092 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 9.133283e-02 | 1.039 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.057256e-01 | 0.976 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.057256e-01 | 0.976 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.057256e-01 | 0.976 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 1.198912e-01 | 0.921 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 1.198912e-01 | 0.921 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.198912e-01 | 0.921 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.198912e-01 | 0.921 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.338334e-01 | 0.873 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.338334e-01 | 0.873 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.338334e-01 | 0.873 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.475555e-01 | 0.831 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.475555e-01 | 0.831 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.475555e-01 | 0.831 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.610610e-01 | 0.793 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.610610e-01 | 0.793 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.345455e-01 | 0.871 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.391751e-02 | 1.076 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 1.564382e-01 | 0.806 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.624821e-02 | 1.017 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.059507e-01 | 0.975 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.059507e-01 | 0.975 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.160189e-01 | 0.935 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.408088e-01 | 0.851 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.481953e-01 | 0.829 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.332049e-02 | 1.030 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.186324e-01 | 0.926 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.369432e-02 | 1.028 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.057256e-01 | 0.976 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.610610e-01 | 0.793 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.564382e-01 | 0.806 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.134404e-01 | 0.945 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 9.133283e-02 | 1.039 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.831132e-02 | 1.054 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.335517e-01 | 0.874 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.057256e-01 | 0.976 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.475555e-01 | 0.831 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 9.133283e-02 | 1.039 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 9.133283e-02 | 1.039 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.198912e-01 | 0.921 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.238826e-01 | 0.907 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.519351e-01 | 0.818 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.824646e-02 | 1.008 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.454049e-01 | 0.837 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.260295e-01 | 0.900 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.133283e-02 | 1.039 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 1.198912e-01 | 0.921 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 1.198912e-01 | 0.921 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.475555e-01 | 0.831 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.475555e-01 | 0.831 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.369787e-02 | 1.077 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.399521e-01 | 0.854 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.264307e-01 | 0.898 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 1.399521e-01 | 0.854 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.944042e-02 | 1.002 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.085837e-01 | 0.964 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.083098e-01 | 0.965 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.291880e-01 | 0.889 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.846974e-02 | 1.053 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.408088e-01 | 0.851 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 9.133283e-02 | 1.039 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.475555e-01 | 0.831 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.509012e-01 | 0.821 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.291880e-01 | 0.889 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.026749e-01 | 0.989 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.481953e-01 | 0.829 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.194524e-01 | 0.923 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.113164e-01 | 0.953 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.620132e-01 | 0.790 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.134404e-01 | 0.945 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.201076e-01 | 0.920 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.338334e-01 | 0.873 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 1.610610e-01 | 0.793 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.137702e-01 | 0.944 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.454049e-01 | 0.837 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.137702e-01 | 0.944 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.500172e-01 | 0.824 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.029773e-01 | 0.987 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 1.057256e-01 | 0.976 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.057256e-01 | 0.976 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.083098e-01 | 0.965 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.509012e-01 | 0.821 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 9.624821e-02 | 1.017 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.099134e-02 | 1.041 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.167822e-01 | 0.933 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.723888e-02 | 1.012 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.612914e-02 | 1.065 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.291880e-01 | 0.889 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.057256e-01 | 0.976 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.198912e-01 | 0.921 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.345455e-01 | 0.871 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.509012e-01 | 0.821 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.164040e-01 | 0.934 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.198912e-01 | 0.921 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.291880e-01 | 0.889 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.557047e-01 | 0.808 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.291880e-01 | 0.889 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.824646e-02 | 1.008 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.624821e-02 | 1.017 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.526882e-01 | 0.816 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.289873e-01 | 0.889 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 1.134404e-01 | 0.945 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.059507e-01 | 0.975 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.092673e-01 | 0.962 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.577142e-01 | 0.802 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.633302e-01 | 0.787 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.999367e-02 | 1.046 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.399521e-01 | 0.854 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.272013e-01 | 0.896 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.249972e-01 | 0.903 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.846974e-02 | 1.053 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.896236e-02 | 1.051 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.509012e-01 | 0.821 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.285483e-02 | 1.032 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.963333e-02 | 1.002 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.240398e-01 | 0.906 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.671844e-01 | 0.777 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.676237e-01 | 0.776 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.710984e-01 | 0.767 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.710984e-01 | 0.767 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.732672e-01 | 0.761 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.732672e-01 | 0.761 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.732672e-01 | 0.761 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.732672e-01 | 0.761 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.743535e-01 | 0.759 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.743535e-01 | 0.759 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.743535e-01 | 0.759 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.743535e-01 | 0.759 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.743535e-01 | 0.759 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.743535e-01 | 0.759 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.743535e-01 | 0.759 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.765880e-01 | 0.753 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.773141e-01 | 0.751 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.789412e-01 | 0.747 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.828587e-01 | 0.738 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.874361e-01 | 0.727 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.874361e-01 | 0.727 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.874361e-01 | 0.727 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.874361e-01 | 0.727 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.874361e-01 | 0.727 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.874361e-01 | 0.727 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.874361e-01 | 0.727 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.874361e-01 | 0.727 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 1.900218e-01 | 0.721 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.961232e-01 | 0.707 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.003121e-01 | 0.698 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.003121e-01 | 0.698 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.003121e-01 | 0.698 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 2.003121e-01 | 0.698 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.003121e-01 | 0.698 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.003121e-01 | 0.698 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 2.003121e-01 | 0.698 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.018963e-01 | 0.695 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.018963e-01 | 0.695 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.046142e-01 | 0.689 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.081490e-01 | 0.682 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.081490e-01 | 0.682 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.111558e-01 | 0.675 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.129850e-01 | 0.672 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.129850e-01 | 0.672 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.129850e-01 | 0.672 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.129850e-01 | 0.672 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.129850e-01 | 0.672 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.129850e-01 | 0.672 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 2.129850e-01 | 0.672 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.129850e-01 | 0.672 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.254578e-01 | 0.647 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.254578e-01 | 0.647 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.254578e-01 | 0.647 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 2.254578e-01 | 0.647 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 2.254578e-01 | 0.647 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.254578e-01 | 0.647 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.254578e-01 | 0.647 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.254578e-01 | 0.647 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.254578e-01 | 0.647 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.254578e-01 | 0.647 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.254578e-01 | 0.647 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.254578e-01 | 0.647 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.254578e-01 | 0.647 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.254578e-01 | 0.647 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.254578e-01 | 0.647 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.254578e-01 | 0.647 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 2.254578e-01 | 0.647 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.254578e-01 | 0.647 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.310120e-01 | 0.636 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.377336e-01 | 0.624 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.377336e-01 | 0.624 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.377336e-01 | 0.624 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.377336e-01 | 0.624 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.377336e-01 | 0.624 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.377336e-01 | 0.624 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.377336e-01 | 0.624 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.377336e-01 | 0.624 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.377336e-01 | 0.624 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.377336e-01 | 0.624 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.377336e-01 | 0.624 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.445501e-01 | 0.612 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.465504e-01 | 0.608 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.486129e-01 | 0.604 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.486129e-01 | 0.604 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.486129e-01 | 0.604 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.498157e-01 | 0.602 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.498157e-01 | 0.602 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.498157e-01 | 0.602 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.498157e-01 | 0.602 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.498157e-01 | 0.602 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.498157e-01 | 0.602 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.498157e-01 | 0.602 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.530322e-01 | 0.597 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.530322e-01 | 0.597 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.530322e-01 | 0.597 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.544912e-01 | 0.594 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.544912e-01 | 0.594 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 2.558896e-01 | 0.592 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.572893e-01 | 0.590 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.603724e-01 | 0.584 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.612067e-01 | 0.583 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 2.617070e-01 | 0.582 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.617070e-01 | 0.582 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.617070e-01 | 0.582 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.617070e-01 | 0.582 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.617070e-01 | 0.582 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.617070e-01 | 0.582 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.617070e-01 | 0.582 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.617070e-01 | 0.582 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.617070e-01 | 0.582 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.658323e-01 | 0.575 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.662550e-01 | 0.575 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.701167e-01 | 0.568 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.701167e-01 | 0.568 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.708586e-01 | 0.567 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.721374e-01 | 0.565 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.721374e-01 | 0.565 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.734105e-01 | 0.563 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.734105e-01 | 0.563 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.734105e-01 | 0.563 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.734105e-01 | 0.563 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.734105e-01 | 0.563 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 2.734105e-01 | 0.563 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.814052e-01 | 0.551 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.838960e-01 | 0.547 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 2.849292e-01 | 0.545 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 2.849292e-01 | 0.545 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.849292e-01 | 0.545 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.849292e-01 | 0.545 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 2.849292e-01 | 0.545 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.849292e-01 | 0.545 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.873260e-01 | 0.542 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.897695e-01 | 0.538 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.962660e-01 | 0.528 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 2.962660e-01 | 0.528 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.962660e-01 | 0.528 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.962660e-01 | 0.528 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 2.962660e-01 | 0.528 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.962660e-01 | 0.528 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.962660e-01 | 0.528 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.002898e-01 | 0.522 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.014978e-01 | 0.521 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.046185e-01 | 0.516 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.046185e-01 | 0.516 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.073502e-01 | 0.512 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.073502e-01 | 0.512 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.074237e-01 | 0.512 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.074237e-01 | 0.512 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.074237e-01 | 0.512 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.074237e-01 | 0.512 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.074237e-01 | 0.512 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.074237e-01 | 0.512 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.074237e-01 | 0.512 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.074237e-01 | 0.512 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.089501e-01 | 0.510 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.089501e-01 | 0.510 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.090163e-01 | 0.510 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.184052e-01 | 0.497 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.184052e-01 | 0.497 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.184052e-01 | 0.497 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.184052e-01 | 0.497 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.184052e-01 | 0.497 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.184052e-01 | 0.497 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.184052e-01 | 0.497 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.184052e-01 | 0.497 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.184052e-01 | 0.497 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.219554e-01 | 0.492 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 3.240704e-01 | 0.489 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.292133e-01 | 0.483 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.292133e-01 | 0.483 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.292133e-01 | 0.483 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 3.292133e-01 | 0.483 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.292133e-01 | 0.483 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 3.292133e-01 | 0.483 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.306537e-01 | 0.481 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.349648e-01 | 0.475 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 3.392996e-01 | 0.469 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.398506e-01 | 0.469 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.398506e-01 | 0.469 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.398506e-01 | 0.469 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.398506e-01 | 0.469 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.398506e-01 | 0.469 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.422264e-01 | 0.466 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.422264e-01 | 0.466 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.479635e-01 | 0.458 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.503199e-01 | 0.456 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.503199e-01 | 0.456 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.503199e-01 | 0.456 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.503199e-01 | 0.456 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.503199e-01 | 0.456 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.503199e-01 | 0.456 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.503199e-01 | 0.456 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.503199e-01 | 0.456 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.505199e-01 | 0.455 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.522916e-01 | 0.453 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.566164e-01 | 0.448 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.566164e-01 | 0.448 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 3.594642e-01 | 0.444 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.606238e-01 | 0.443 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.606238e-01 | 0.443 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.606238e-01 | 0.443 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.606238e-01 | 0.443 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.606238e-01 | 0.443 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.606238e-01 | 0.443 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.606238e-01 | 0.443 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 3.606238e-01 | 0.443 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 3.606238e-01 | 0.443 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.651740e-01 | 0.438 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.652544e-01 | 0.437 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 3.652544e-01 | 0.437 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.695665e-01 | 0.432 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.695665e-01 | 0.432 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.707649e-01 | 0.431 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.707649e-01 | 0.431 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.707649e-01 | 0.431 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 3.753589e-01 | 0.426 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.765345e-01 | 0.424 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.807457e-01 | 0.419 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.807457e-01 | 0.419 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.807457e-01 | 0.419 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.807457e-01 | 0.419 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.807457e-01 | 0.419 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 3.807457e-01 | 0.419 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.807457e-01 | 0.419 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.807457e-01 | 0.419 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.817482e-01 | 0.418 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.905689e-01 | 0.408 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.905689e-01 | 0.408 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.905689e-01 | 0.408 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.905689e-01 | 0.408 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.905689e-01 | 0.408 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.905689e-01 | 0.408 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.911713e-01 | 0.408 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.923738e-01 | 0.406 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.989970e-01 | 0.399 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.989970e-01 | 0.399 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.002368e-01 | 0.398 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.002368e-01 | 0.398 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 4.002368e-01 | 0.398 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.002368e-01 | 0.398 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.045545e-01 | 0.393 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.097520e-01 | 0.387 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.097520e-01 | 0.387 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.097520e-01 | 0.387 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.097520e-01 | 0.387 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.097520e-01 | 0.387 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 4.097520e-01 | 0.387 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.097520e-01 | 0.387 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.097520e-01 | 0.387 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.100875e-01 | 0.387 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.100875e-01 | 0.387 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.119862e-01 | 0.385 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.155954e-01 | 0.381 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.191167e-01 | 0.378 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.191167e-01 | 0.378 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.191167e-01 | 0.378 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.191167e-01 | 0.378 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.191167e-01 | 0.378 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.191167e-01 | 0.378 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.191167e-01 | 0.378 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.191167e-01 | 0.378 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.207828e-01 | 0.376 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 4.265332e-01 | 0.370 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.283335e-01 | 0.368 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.283335e-01 | 0.368 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.283335e-01 | 0.368 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.283335e-01 | 0.368 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.283335e-01 | 0.368 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.283335e-01 | 0.368 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.319621e-01 | 0.365 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.338103e-01 | 0.363 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.374046e-01 | 0.359 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 4.374046e-01 | 0.359 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.374046e-01 | 0.359 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.374046e-01 | 0.359 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.374046e-01 | 0.359 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.374046e-01 | 0.359 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.374046e-01 | 0.359 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.417309e-01 | 0.355 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.463323e-01 | 0.350 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 4.463323e-01 | 0.350 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.480826e-01 | 0.349 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 4.551188e-01 | 0.342 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.551188e-01 | 0.342 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.551188e-01 | 0.342 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.582780e-01 | 0.339 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.582780e-01 | 0.339 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.582780e-01 | 0.339 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.586863e-01 | 0.338 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.630599e-01 | 0.334 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.637665e-01 | 0.334 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.637665e-01 | 0.334 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.637665e-01 | 0.334 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.637665e-01 | 0.334 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.637665e-01 | 0.334 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.637665e-01 | 0.334 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.637665e-01 | 0.334 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.637665e-01 | 0.334 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.661275e-01 | 0.331 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.699873e-01 | 0.328 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.705517e-01 | 0.327 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.722774e-01 | 0.326 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.722774e-01 | 0.326 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.722774e-01 | 0.326 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 4.722774e-01 | 0.326 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 4.722774e-01 | 0.326 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.743687e-01 | 0.324 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.795351e-01 | 0.319 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 4.806538e-01 | 0.318 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.806538e-01 | 0.318 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.806538e-01 | 0.318 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.806538e-01 | 0.318 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.806538e-01 | 0.318 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 4.806538e-01 | 0.318 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 4.897744e-01 | 0.310 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.947150e-01 | 0.306 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.970113e-01 | 0.304 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 4.970113e-01 | 0.304 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.970113e-01 | 0.304 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.970113e-01 | 0.304 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.970113e-01 | 0.304 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 4.970113e-01 | 0.304 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.049965e-01 | 0.297 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.074664e-01 | 0.295 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.098706e-01 | 0.293 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.098706e-01 | 0.293 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.105174e-01 | 0.292 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.128555e-01 | 0.290 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.128555e-01 | 0.290 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.148134e-01 | 0.288 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.197234e-01 | 0.284 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.205902e-01 | 0.284 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.205902e-01 | 0.284 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.205902e-01 | 0.284 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.205902e-01 | 0.284 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 5.205902e-01 | 0.284 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.205902e-01 | 0.284 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.246002e-01 | 0.280 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.282025e-01 | 0.277 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.282025e-01 | 0.277 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.282025e-01 | 0.277 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.282025e-01 | 0.277 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.282025e-01 | 0.277 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.282025e-01 | 0.277 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.282025e-01 | 0.277 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.287569e-01 | 0.277 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.356945e-01 | 0.271 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.356945e-01 | 0.271 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.356945e-01 | 0.271 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.390301e-01 | 0.268 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.430679e-01 | 0.265 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 5.430679e-01 | 0.265 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.503247e-01 | 0.259 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 5.503247e-01 | 0.259 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.574666e-01 | 0.254 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.574666e-01 | 0.254 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.577967e-01 | 0.254 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.624030e-01 | 0.250 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.644956e-01 | 0.248 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 5.644956e-01 | 0.248 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.644956e-01 | 0.248 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.669749e-01 | 0.246 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 5.714133e-01 | 0.243 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.714133e-01 | 0.243 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.714133e-01 | 0.243 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.714133e-01 | 0.243 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.782216e-01 | 0.238 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 5.782216e-01 | 0.238 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.782216e-01 | 0.238 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 5.849222e-01 | 0.233 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.878215e-01 | 0.231 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 5.893180e-01 | 0.230 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.893180e-01 | 0.230 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.915167e-01 | 0.228 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.915167e-01 | 0.228 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.936829e-01 | 0.226 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.980068e-01 | 0.223 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 5.980068e-01 | 0.223 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.043942e-01 | 0.219 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 6.106805e-01 | 0.214 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.106805e-01 | 0.214 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.168673e-01 | 0.210 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.168673e-01 | 0.210 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.260270e-01 | 0.203 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.314116e-01 | 0.200 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.348463e-01 | 0.197 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.354314e-01 | 0.197 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 6.365233e-01 | 0.196 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.406505e-01 | 0.193 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.406505e-01 | 0.193 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.406505e-01 | 0.193 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.433682e-01 | 0.192 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.463628e-01 | 0.190 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 6.463628e-01 | 0.190 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.519846e-01 | 0.186 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.525663e-01 | 0.185 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 6.575175e-01 | 0.182 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.575175e-01 | 0.182 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.575175e-01 | 0.182 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.575175e-01 | 0.182 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.575175e-01 | 0.182 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.575175e-01 | 0.182 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.588331e-01 | 0.181 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 6.629626e-01 | 0.179 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.629626e-01 | 0.179 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.657146e-01 | 0.177 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.680997e-01 | 0.175 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.683216e-01 | 0.175 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 6.683216e-01 | 0.175 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.735957e-01 | 0.172 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.735957e-01 | 0.172 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.735957e-01 | 0.172 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.735957e-01 | 0.172 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.737583e-01 | 0.171 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 6.787862e-01 | 0.168 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.787862e-01 | 0.168 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 6.804630e-01 | 0.167 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 6.838945e-01 | 0.165 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.838945e-01 | 0.165 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 6.889890e-01 | 0.162 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 6.938696e-01 | 0.159 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.987389e-01 | 0.156 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.987389e-01 | 0.156 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.020197e-01 | 0.154 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.035311e-01 | 0.153 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.035311e-01 | 0.153 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.117794e-01 | 0.148 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.120831e-01 | 0.147 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.128889e-01 | 0.147 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.128889e-01 | 0.147 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 7.128889e-01 | 0.147 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 7.174568e-01 | 0.144 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 7.174568e-01 | 0.144 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.263766e-01 | 0.139 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.263766e-01 | 0.139 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.267397e-01 | 0.139 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.350159e-01 | 0.134 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.350159e-01 | 0.134 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.350159e-01 | 0.134 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.350159e-01 | 0.134 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 7.405811e-01 | 0.130 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.415670e-01 | 0.130 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.433835e-01 | 0.129 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.474680e-01 | 0.126 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 7.474680e-01 | 0.126 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.474680e-01 | 0.126 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.582174e-01 | 0.120 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 7.582174e-01 | 0.120 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.593372e-01 | 0.120 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.593372e-01 | 0.120 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 7.593372e-01 | 0.120 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.610543e-01 | 0.119 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.631687e-01 | 0.117 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.631687e-01 | 0.117 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.638625e-01 | 0.117 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.693932e-01 | 0.114 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.693932e-01 | 0.114 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.743026e-01 | 0.111 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.743026e-01 | 0.111 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.984066e-01 | 0.098 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.046716e-01 | 0.094 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.050421e-01 | 0.094 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.062197e-01 | 0.094 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 8.077839e-01 | 0.093 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.108468e-01 | 0.091 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.108468e-01 | 0.091 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.120156e-01 | 0.090 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.120156e-01 | 0.090 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.197469e-01 | 0.086 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.226198e-01 | 0.085 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.231460e-01 | 0.085 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.254472e-01 | 0.083 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 8.282297e-01 | 0.082 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.325333e-01 | 0.080 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.363148e-01 | 0.078 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 8.440208e-01 | 0.074 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.537361e-01 | 0.069 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 8.630442e-01 | 0.064 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.671903e-01 | 0.062 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.693096e-01 | 0.061 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.734477e-01 | 0.059 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.774553e-01 | 0.057 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.794114e-01 | 0.056 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.887351e-01 | 0.051 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.905118e-01 | 0.050 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.939809e-01 | 0.049 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.939809e-01 | 0.049 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.939809e-01 | 0.049 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.037448e-01 | 0.044 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.052827e-01 | 0.043 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.067961e-01 | 0.042 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.133382e-01 | 0.039 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.161894e-01 | 0.038 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.231832e-01 | 0.035 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.324795e-01 | 0.030 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.366984e-01 | 0.028 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.411006e-01 | 0.026 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.416045e-01 | 0.026 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.486786e-01 | 0.023 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.526593e-01 | 0.021 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.611543e-01 | 0.017 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.616279e-01 | 0.017 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.624480e-01 | 0.017 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.637927e-01 | 0.016 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.646075e-01 | 0.016 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.668243e-01 | 0.015 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.708515e-01 | 0.013 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.717798e-01 | 0.012 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.718689e-01 | 0.012 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.735489e-01 | 0.012 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.782202e-01 | 0.010 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.796860e-01 | 0.009 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.817762e-01 | 0.008 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.820692e-01 | 0.008 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.917749e-01 | 0.004 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.969593e-01 | 0.001 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.990153e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.992908e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.998540e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999185e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999345e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999984e-01 | 0.000 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.000000e+00 | 0.000 | 1 | 1 |